Adsorption to Container Surfaces

Adsorption is what happens when a peptide leaves solution and sticks to the solid it is touching: borosilicate glass, polypropylene, the polyvinyl chloride of an infusion set, a filter membrane. The driving forces are the ones that govern folding, hydrophobic patches finding a hydrophobic surface and charged residues finding an oppositely charged one. Because a surface saturates rather than removing a fixed proportion, the loss is governed by the ratio of surface area to volume and by absolute concentration, so a molecule unaffected in a concentrated vial can largely vanish from a dilute bag.

Insulin is the textbook case: losses to polyvinyl chloride bags and giving sets have been documented for decades and are why intensive-care practice primes the line. Oxytocin, calcitonin and vasopressin behave comparably in dilute aqueous solution. Formulators counter it with a surfactant such as polysorbate 20 or 80 that occupies the interface preferentially and with low-binding polypropylene labware.

The practical consequence is that a stated concentration describes what went in, not what comes out. Anything increasing surface exposure raises the loss: a longer line, an extra filtration step, repeated transfers between containers. It is also a live source of analytical error, since a stability study run in glass will not predict behaviour in a plastic device.

The misreading worth naming is treating adsorption as degradation. Adsorbed peptide is not broken, so a chromatogram of the remaining solution looks immaculate while much of the material sits on the wall, and a purity assay never flags it; only a mass-balance or recovery measurement will. Grey-market discussion inverts this, attributing a fall in observed effect to the peptide degrading when concentration-dependent surface loss is the commoner explanation.